Table 2.
Datasets | Number compounds | Risk categorization tested | Figure/Table |
---|---|---|---|
Dataset 1 | 31 | TdP+: R1, R2, R3 categories (RCOD) | Figure 3, Table 4 |
(Mirams et al., 2011) | |||
Dataset 2 | 55 | TdP+: R1, R2, R3, CM1, CM2, CM3 categories | Figure 3, Table 4 |
(Kramer et al., 2013) | or label warning (RCOD) | ||
Dataset 3 | 12 | TdP+: R1, R2, R3 categories (RCOD) | Figure 3, Table 4 |
(Okada et al., 2015) | |||
Dataset 4 | 86 | TdP+: CM1 and CH1 categories, | Figure 3, Table 4 |
(Lancaster and Sobie, 2016) | Drugs in CM2 and CM3 if label warning (RCOD) | ||
Dataset 5 | 30 | TdP+: R1, R2, R3, CH1, CM1 category | Figures 2A,B, left panel, Figure 4 |
(Crumb et al., 2016) | or label warning | Tables 4, 5 | |
TdP+: CM1 and CM2 | Figures 2A,B, right panel, Figure 4, Table 5 | ||
TdP+: CM1 | Table 5 | ||
TdP+: CM1 and CM3 | Table 5 | ||
Dataset 6 | 57 | TdP+: CM1 | Figure 3, Table 4 |
(Ando et al., 2017) | |||
Dataset 7 | 12 | TdP+: CP1 and CP2 category | Figure 3, Table 4 |
(Li et al., 2017) | High: CP1 Intermediate: CP2 Low: CP3 (RCOD) | Figure 6 | |
Dataset 8 | 197 | TdP+ R1, R2, R3, CH1, CM1 category or label warning | Figure 5 |
(Combined Datasets 1, 2, 3, 5, 6, and 7) | TdP+: CM1 and CM2 | Table 6 | |
TdP+: CM1 | Table 6 | ||
TdP+: CM1 and CM3 | Table 6 | ||
Dataset 9 | 26 | High: CP1 Intermediate: CP2 Low: CP3 (RCOD) | Figure 6 |
(Fermini et al., 2016) | |||
(IC50,channel extracted from Datasets 1, 2, 3, 5, 6, and 7) |
“Risk categorization tested” column refers to the TdP risk definition (see more info on definitions in the text) used to test/train the particular datasets, and the “Figure/Table” column list the corresponding Figure and Table numbers where the results of the particular dataset and risk categorization pair are reported. The IC50 values and risk category of individual drug for each datasets are also reported in the Supplemental Material.